Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of PF-04427429 in healthy women volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Pain

Drugs mentioned

• PF-04427429

Snippet

Sponsor: Pfizer | Conditions: Pain, Migraine Disorders | Phase 1 | Status: COMPLETED